809 Phase 2 trial of neoadjuvant and adjuvant PD-1 checkpoint blockade in local-regionally advanced, resectable HNSCC indicates pathological response is associated with high disease-free survival

Trisha Wise-Draper; Shuchi Gulati; Vinita Takiar; Sarah Palackdharry; Francis Worden; Matthew Old; John Kaczmar; Neal Dunlap; Benjamin Hinrichs; Diana Bell; Yash Patil; Muhammad Kashif Riaz; Layne Weatherford; Aubrey Hamilton; Sheena Lanverman; Michelle Mierzwa; Keith Casper; Jonathan Mark; Alice Tang; Chad Zender; Ann Gillenwater; Mario Medvedovich; J Jack Lee; Roman Jandarov; Maura Gillison

doi:10.1136/jitc-2020-SITC2020.0809

Article info

Late-breaking abstracts

Clinical trials in-progress

809 Phase 2 trial of neoadjuvant and adjuvant PD-1 checkpoint blockade in local-regionally advanced, resectable HNSCC indicates pathological response is associated with high disease-free survival

Authors

Trisha Wise-Draper University of Cincinnati Cancer Center, Cincinnati, OH, USA PubMed articles Google scholar articles
Shuchi Gulati University of Cincinnati Cancer Center, Cincinnati, OH, USA PubMed articles Google scholar articles
Vinita Takiar University of Cincinnati Cancer Center, Cincinnati, OH, USA PubMed articles Google scholar articles
Sarah Palackdharry University of Cincinnati Cancer Center, Cincinnati, OH, USA PubMed articles Google scholar articles
Francis Worden University of Michigan, Ann Arbor, MI, USA PubMed articles Google scholar articles
Matthew Old Ohio State University, Columbus, OH, USA PubMed articles Google scholar articles
John Kaczmar MUSC, Charleston, SC, USA PubMed articles Google scholar articles
Neal Dunlap University of Louisville, Louisville, KY, USA PubMed articles Google scholar articles
Benjamin Hinrichs University of Cincinnati Cancer Center, Cincinnati, OH, USA PubMed articles Google scholar articles
Diana Bell MD Anderson, Houston, USA PubMed articles Google scholar articles
Yash Patil University of Cincinnati Cancer Center, Cincinnati, OH, USA PubMed articles Google scholar articles
Muhammad Kashif Riaz University of Cincinnati Cancer Center, Cincinnati, OH, USA PubMed articles Google scholar articles
Layne Weatherford University of Cincinnati Cancer Center, Cincinnati, OH, USA PubMed articles Google scholar articles
Aubrey Hamilton University of Cincinnati Cancer Center, Cincinnati, OH, USA PubMed articles Google scholar articles
Sheena Lanverman University of Cincinnati Cancer Center, Cincinnati, OH, USA PubMed articles Google scholar articles
Michelle Mierzwa University of Michigan, Ann Arbor, MI, USA PubMed articles Google scholar articles
Keith Casper University of Michigan, Ann Arbor, MI, USA PubMed articles Google scholar articles
Jonathan Mark East Virginia medical school, Norfolk, VA, USA PubMed articles Google scholar articles
Alice Tang University of Cincinnati Cancer Center, Cincinnati, OH, USA PubMed articles Google scholar articles
Chad Zender University of Cincinnati Cancer Center, Cincinnati, OH, USA PubMed articles Google scholar articles
Ann Gillenwater MD Anderson, Houston, USA PubMed articles Google scholar articles
Mario Medvedovich University of Cincinnati, Cincinnati, OH, USA PubMed articles Google scholar articles
J Jack Lee MD Anderson, Houston, USA PubMed articles Google scholar articles
Roman Jandarov University of Cincinnati, Cincinnati, OH, USA PubMed articles Google scholar articles
Maura Gillison MD Anderson, Houston, USA PubMed articles Google scholar articles

Citation

Wise-Draper T, Gulati S, Takiar V, et al

809 Phase 2 trial of neoadjuvant and adjuvant PD-1 checkpoint blockade in local-regionally advanced, resectable HNSCC indicates pathological response is associated with high disease-free survival

Journal for ImmunoTherapy of Cancer 2020;8:doi: 10.1136/jitc-2020-SITC2020.0809

Online issue publication

December 12, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password